Back to Test Catalogue

Infliximab with Reflex Antibodies, Serum

Test ID: INFLIXSPH S

Test

Aliases/Synonyms

Remicade; Inflectra; Renflexis

Method

Various

Method Description

Infliximab Quantitation: Mass Spectrometry
Infliximab Antibodies: semi-quantitative ELISA (Immunodiagnostik)

Report Includes

Infliximab; Infliximab Antibodies

Specimens

Serum

Clinical Utility

Infliximab Antibodies will only be tested (and billed) when the measured Infliximab concentration is subtherapeutic (Infliximab ≤ 5 µg/mL).

Test Location

St. Paul's Hospital Laboratory, 1081 Burrard St, Vancouver, BC V6Z 1Y6

Test Version

18-Oct-2023

Specimen

Specimens

Serum

Collection Containers

Preferred

Red top (no additive)

Acceptable

Gold Top (clot activator and gel)

Sample Volume

3 mL

Minimum Volume

2 mL

Collection & Handling

Collection Instructions

Collect trough specimen immediately prior to the next infusion.

Handling Information

Please indicate date/time of last infusion. Store and send cold or frozen.

Additional Information

Date/time of last infusion is requested to facilitate appropriate interpretation and to assist the test provider in troubleshooting unusual findings and in support of appropriate utilization (e.g., collection at true trough).

Stability

Ambient 7 days
Refrigerated 7 days
Frozen 28 days

Test Version

18-Oct-2023

Performance / Interpretation

Method

Various

Method Description

Infliximab Quantitation: Mass Spectrometry
Infliximab Antibodies: semi-quantitative ELISA (Immunodiagnostik)

Turnaround Time

9 days

Results

Name Units Reference Range Conversion Factor
Infliximab µg/mL
  • Therapeutic: > 5.0 (see comment below)
When infliximab trough concentration is greater than 5.0 µg/mL, clinically relevant antibodies to infliximab are unlikely and reflex antibody testing is not performed.
Infliximab Antibodies
  • Not detected
Interpretation
1+: Antibodies to infliximab detected, clinical significance uncertain.
2+: Antibodies to infliximab detected at significant concentrations.
3+: Antibodies to infliximab detected at significant concentrations.

Test Location

St. Paul's Hospital Laboratory, 1081 Burrard St, Vancouver, BC V6Z 1Y6

Test Version

18-Oct-2023

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
Multiple 0HL7 codes

Test Version

18-Oct-2023